Cargando…

Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation

Detalles Bibliográficos
Autores principales: Megna, Matteo, Villani, Alessia, Potestio, Luca, Camela, Elisa, Fabbrocini, Gabriella, Ocampo‐Garza, Sonia Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541432/
https://www.ncbi.nlm.nih.gov/pubmed/35770675
http://dx.doi.org/10.1111/dth.15679
_version_ 1784803923136086016
author Megna, Matteo
Villani, Alessia
Potestio, Luca
Camela, Elisa
Fabbrocini, Gabriella
Ocampo‐Garza, Sonia Sofia
author_facet Megna, Matteo
Villani, Alessia
Potestio, Luca
Camela, Elisa
Fabbrocini, Gabriella
Ocampo‐Garza, Sonia Sofia
author_sort Megna, Matteo
collection PubMed
description
format Online
Article
Text
id pubmed-9541432
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-95414322022-10-14 Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation Megna, Matteo Villani, Alessia Potestio, Luca Camela, Elisa Fabbrocini, Gabriella Ocampo‐Garza, Sonia Sofia Dermatol Ther Letters John Wiley & Sons, Inc. 2022-07-09 2022-09 /pmc/articles/PMC9541432/ /pubmed/35770675 http://dx.doi.org/10.1111/dth.15679 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letters
Megna, Matteo
Villani, Alessia
Potestio, Luca
Camela, Elisa
Fabbrocini, Gabriella
Ocampo‐Garza, Sonia Sofia
Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation
title Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation
title_full Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation
title_fullStr Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation
title_full_unstemmed Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation
title_short Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation
title_sort adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541432/
https://www.ncbi.nlm.nih.gov/pubmed/35770675
http://dx.doi.org/10.1111/dth.15679
work_keys_str_mv AT megnamatteo adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation
AT villanialessia adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation
AT potestioluca adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation
AT camelaelisa adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation
AT fabbrocinigabriella adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation
AT ocampogarzasoniasofia adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation